Descripción
La descripción detallada está siendo preparada por nuestro equipo clínico.
Ensayos Clínicos
NCT05541822
Fase 2
Reclutando
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation
United States, South Korea, Taiwan
NCT05498428
Fase 2
Reclutando
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
United States, Brazil, China, France, Germany, Israel, Italy, Japan, Malaysia, S